Clarity emerges on Indian health ministry’s pharma trademarks directive

Towards the end of last year, reports emerged from India suggesting that regulatory authorities in the country might be planning to restrict or even ban the use of brand names in the sale of pharmaceutical products. However, as more detail has emerged it is apparent the move is not the threat to trademarks that some speculated.

Get unlimited access to all WTR content